Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
478.00    0.00 (0.00%)
Bid:
477.00
Ask:
480.00
Spread: 3.00 (0.629%)
Market Cap: £787.94m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Trading Update

18 Jan 2011 07:00

RNS Number : 6114Z
Oakley Capital Investments Limited
18 January 2011
 



 

 

18 January 2011

 

Oakley Capital Investments Limited

 

Trading Update for the 12 months ended 31 December 2010

 

·; NAV (unaudited) expected to be in the range of £1.64 - £1.67

o Over 16% up from year ended 31 December 2009

o Over 18p up from 30 June 2010

 

Oakley Capital Investments Limited (AIM: OCL, "OCIL"), the AIM-listed company established to provide investors with access to the investment strategy being pursued by Oakley Capital Private Equity L.P. (the "Limited Partnership" or the "Fund"), today announces a trading update for the 12 months ended 31 December 2010.

 

The Limited Partnership's portfolio of investments comprises Daisy Group plc, Verivox Holdings Limited, Headland Media Limited, Monument Securities Limited, BDO Investment Management Limited and Time Out Limited. Oakley Capital Limited, OCIL's investment adviser, estimates that the Company's net asset value per share, which is subject to the completion of the 31 December 2010 audit of both the Limited Partnership and the Company, will be in the range of £1.64 to £1.67. The OCIL net asset value is made up of cash, the investment in the Limited Partnership and loans provided to a number of the portfolio companies.

 

 

Peter Dubens, Director, commented:

"The second half of 2010 has been very busy for the Limited Partnership with its first realisation in the Fund and two new investments, in BDO Investment Management and Time Out. The exit was from Host Europe Corporation Limited, the Fund's previous largest investment, for total consideration of £222 million, after a holding period of just 31 months.

 

"The Fund's portfolio companies continue to perform well with an improvement in underlying profitability in the remaining investments driving an increase in net asset value per share of at least 14p in the year."

 

For further information please contact:

Oakley Capital Investments Limited

+44 20 7766 6900

Peter Dubens (Director)

Financial Dynamics

+44 20 7831 3113

Juliet Clarke / James Macey-White

Liberum Capital Limited (Nominated Adviser & Broker)

+44 20 3100 2000

Steve Pearce / Steven Tredget

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSFEFMWFFSEDF
Date   Source Headline
15th Mar 20215:35 pmRNSHolding(s) in Company
11th Mar 20217:00 amRNSFinal Results for the Year Ended 31 December 2020
9th Mar 20212:05 pmEQSHardman & Co Research : Hardman Talks | Oakley Capital Investments Management Discussion
1st Mar 20217:00 amRNSRefinancing of Career Partner Group
23rd Feb 20217:00 amRNSNotice of Results and Investor Presentation
19th Feb 20217:00 amRNSInvestment in Dexters
10th Feb 20217:00 amRNSDirector Dealing
29th Jan 20214:42 pmRNSDirector Dealing
27th Jan 20215:06 pmRNSDirector Dealing
27th Jan 20217:00 amRNSTrading update for the year ended 31 December 2020
26th Jan 20217:00 amRNSInvestment in idealista
7th Jan 20217:00 amRNSSale of the DWS division of the Daisy Group
22nd Dec 20204:11 pmRNSHolding(s) in Company
11th Dec 20202:33 pmRNSDirector Declaration
4th Dec 20203:58 pmRNSHolding(s) in Company
3rd Dec 20204:50 pmEQSHardman & Co Research: Oakley Capital Investments (OCI): NAV: conservative, robust and with growth upside
3rd Dec 20201:52 pmRNSTransaction in Own Shares
25th Nov 20207:00 amRNSHolding(s) in Company
23rd Oct 20207:00 amRNSDirector/PDMR Shareholding
22nd Oct 20207:00 amRNSAcquisition of WindStar Medical
6th Oct 202012:42 pmRNSHolding(s) in Company
6th Oct 20207:00 amRNSTransaction in Own Shares (Amendment)
2nd Oct 20204:33 pmRNSTransaction in Own Shares
2nd Oct 20207:00 amRNSShare Buy-Back Programme
1st Oct 20207:00 amRNSAcquisition of 7NXT
30th Sep 20201:54 pmRNSAppointment of Non-Executive Director
17th Sep 20207:00 amRNSOakley sells Casa.it to EQT
10th Sep 20207:00 amRNSResults for the six months ended 30 June 2020
1st Sep 20207:20 amEQSHardman & Co Research: Oakley Capital Investments (OCI) - initiation of coverage: 'When it rains gold, put out the bucket'
4th Aug 20203:09 pmRNSHolding(s) in Company
29th Jul 20206:15 pmRNSTransaction in Own Shares
29th Jul 20207:00 amRNSTrading update for the six months ended 30 June 20
15th Jul 20209:30 amRNSKepler Trust Intelligence: New Research
6th Jul 20207:00 amRNSCapital Commitment
30th Jun 20207:00 amRNSDirectorate Change
24th Jun 20206:02 pmRNSDirector Dealing
22nd Jun 202012:22 pmRNSHolding(s) in Company
19th Jun 20205:38 pmRNSDirector Dealing
19th Jun 20207:01 amRNSDirector Dealing
19th Jun 20207:00 amRNSDirector Dealing
18th Jun 20205:57 pmRNSHolding(s) in Company
18th Jun 20204:42 pmRNSTransaction in Own Shares
18th Jun 20207:00 amRNSShare Buy-Back
1st Jun 20202:25 pmRNSDirector Declaration
27th May 20205:01 pmRNSHolding(s) in Company
27th May 20207:00 amRNSResult of Annual General Meeting
22nd May 20204:33 pmRNSTime Out equity fundraise and OCI loan repayment
19th May 20207:00 amRNSDirector Declaration
7th May 20207:00 amRNSDirectorate Change and Total Voting Rights
1st May 20207:00 amRNSNotice of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.